CLOs on the Move

Stimwave Technologies

www.stimwavefreedom.com

 
Stimwave Technologies Inc is a privately-held medical device company engaged in the development, manufacture, commercialization and marketing of wireless microsize injectable medical devices for neurology markets. Stimwave strives to improve people`s lives through utilizing wireless neurostimulation technology that enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Ez Way

Ez Way is a Clarinda, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Essential Medical Supply

Essential Medical Supply is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Butler John O Co Inc

Butler John O Co Inc is a Bensenville, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Maddak

Maddak is a Pequannock, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sight Sciences

Founded in 2011, Sight Sciences develops and commercializes intelligently designed and engineered products that target the underlying causes of the world`s most prevalent eye diseases. The company`s surgical glaucoma product portfolio features the OMNI Surgical System, a dually indicated MIGS device that facilitates the performance of both ab interno trabeculotomy and transluminal viscoelastic delivery. Using proprietary multi-modal functionality, OMNI allows surgeons to target all three sources of resistance in the conventional outflow pathway (trabecular meshwork, Schlemm`s canal and collector channels) with a single device and single corneal incision. The company`s non-surgical dry eye product portfolio consists of the TearCare for ophthalmologists and optometrists. TearCare is a software-controlled, wearable, therapeutic eyelid technology designed to melt and clear obstructions of the meibomian glands within the eyelids. Leveraging the full functionality of the blinking eye, proprietary SmartLid™ technology is designed to conform to all eyelid anatomies and achieve therapeutic meibum melting temperatures at the tarsal conjunctiva thereby clearing meibomian gland obstructions while sparing the cornea. Improved meibum production results in a higher quality lipid layer and higher quality tears.